Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan

J Alzheimers Dis. 2010;21(3):775-80. doi: 10.3233/JAD-2010-100513.

Abstract

High plasma lipoprotein phospholipase A2 activity (Lp-PLA2) is reported to be a risk factor for dementia. A loss of function polymorphism in the Lp-PLA2 gene - PLA2G7 V279F - is found almost exclusively in Asians. In 1,952 subjects with late-onset AD and 2,079 non-demented controls recruited from Japan, the PLA2G7 null allele was not associated with risk or age at onset of AD: logistic regression OR 0.98 (95% CI 0.86-1.12, p=0.81) per additional null allele, adjusted for age/age at onset, gender, and APOE ε4. Genetic deficiency of Lp-PLA2 activity is not associated with a reduced risk of AD in the Japanese population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Alleles
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Asian People / genetics
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Humans
  • Japan
  • Mutation
  • Phospholipases A2 / genetics*
  • Polymorphism, Genetic
  • Risk*

Substances

  • Apolipoproteins E
  • Phospholipases A2
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • PLA2G7 protein, human